Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Product name:
YTTRIGA
DIN:
02470543
Product Monograph/Veterinary Labelling:
Date:
2018-06-01
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ECKERT & ZIEGLER RADIOPHARMA GMBH
Robert-Rossle-Strasse 10
Berlin
--
Germany
13125
Class:
Radiopharmaceutical
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule C
American Hospital Formulary Service (AHFS): See footnote 3
78:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V10AA YTTRIUM 90 Y COMPOUNDS
Active ingredient group (AIG) number:See footnote5
0152618002
| Active ingredient(s) | Strength |
|---|---|
| YTTRIUM-90 CHLORIDE | 300 GBQ / VIAL |